Recursion CEO Chris Gibson: There's real opportunity to leverage A.I. to speed up drug development
Chris Gibson, Recursion CEO, joins ‘Closing Bell Overtime’ to talk the company’s stock pop after announcing an A.I. deal with Nvidia, the utilization of A.I. in the biotech space and more.
